Yu go dɔn yɛri se naw, dɛn dɔn gɛt rili advans, targeted therapies fɔ siriɔs sik dɛm lɛk kansa ɛn at at sik. So, tide wi go tɔk bɔt wan wɔndaful tin we dɛn dɔn fɛn pan mɛrɛsin we de tek wan rili impɔtant ples pan dɛn kayn advans tritmɛnt ya. Dat na "Monoclonal Antibodies". Pan ɔl we i kin tan lɛk se di nem kɔmplikt smɔl, wi kin ɔndastand aw i de wok simpul wan.
Fɔ tɔk am simpul wan, wetin na dɛn Monoclonal Antibodies ya?
fכ כndastand dis, wi fכs nid fכ lan bכt di " antibodies " dεm na wi bכdi. Antibodi na spɛshal sojaman dɛn na wi imyun sistɛm. We sɔntin we na ɔda kɔntri (wi kɔl dɛn antijen ) lɛk jem we de mek pɔsin sik ɔ kansa sɛl kam insay wi bɔdi, dɛn antibodi ya kin go fɔ no di ɛnimi, kech am, ɛn bigin fɔ pwɛl am.
Imajin if wi kin mek dɛn sem sojaman dɛn ya we sabi du dɛn wok na wi bɔdi, wit bɔku bɔku ɔda wan dɛn, na wan lɛb? Na dat na di monoklɔnal antibodi dɛm. Dis na atifishal antibodi dɛm we dɛn mek na lab.
"Mono" min "wan." "Klɔnal" min "klon." Dat min se, dɛn tin ya na bɔku bɔku ɛksaktɔl kɔpi dɛn fɔ wan antibodi. Ɛni kɔpi na di sem. Dɛn mek dɛn fɔ tɔch ɛn atak di sem antijen. If yu luk di mɛrɛsin bɔtul we yu dɔktɔ gi yu, di nem fɔ dis kayn mɛrɛsin kin dɔn wit di lɛta dɛn "-mab" (e.g. Trastuzumab, Adalimumab).
Wetin na di difrɛns bitwin Monoclonal ɛn Polyclonal Antibodies?
Dis difrɛns de bak na di nem dɛn. "Mono" min wan, ɛn "poly" min sɔm. Imajin se na wan kayn ɛnimi nɔmɔ yu gɛt. Monoclonal Antibodies de wok lɛk fɔ sɛn spɛshal tren kɔmando we kin atak da ɛnimi de nɔmɔ.
Na di ɔda say, Polyclonal Antibodies tan lɛk wan ami we gɛt sojaman dɛn we gɛt difrɛn abiliti, we ebul fɔ atak difrɛn kayn ɛnimi dɛn. dis dεm lεk di antibodi dεm we wi bכdi de prodyuz nכmal wan, we dεn mek wit difrεn antibodi sεl dεm, εn dεn kin atak mכr dan wan tכp εnimi (antijen).
| Kwaliti | Mɔnoklɔnal Antibodi dɛn | Poliklɔnal Antibodi dɛn |
|---|---|---|
| Mek sɔntin | Klon dεm frכm di sem antibodi sεl | Frɔm difrɛn antibodi sɛl dɛn |
| Gol | Na wan patikyula antijen nɔmɔ | I kin atak sɔm difrɛn ɛnimi dɛn (antijen dɛn) . |
| Aw fɔ yuz am | Fɔ tritmɛnt we dɛn dɔn tɔk bɔt ɛn fɔ mek dɛn no di pɔsin we dɛn want fɔ no mɔ | Fכ nכmal imyun rεspכns dεm εn sכm diagnostik dεm |
Us kɔndishɔn dɛn kin trit wit dis tritmɛnt we?
Monoclonal antibodies na tru tru wan wɔndaful tul we yu kin yuz fɔ trit bɔku bɔku sik dɛn, frɔm di bɛlɛ tɛst kit we yu kin yuz na os to di kayn kansa we siriɔs pas ɔl.
Dis dɔŋ ya na sɔm pan di tin dɛm wae dɛn kin yuse dis tritmɛnt fɔ.
| Di sik kategori | Ɛgzampul dɛn |
|---|---|
| Kansa | Brɔst kansa, kɔlon kansa, lɔng kansa, lukimiya |
| Inflammatory ɛn Ɔtoimyun Disɔda | Rimatɔyd Atraytis, Kron sik, Psoriasis, Alɛji |
| Infεkshכn dεm | Vayral infεkshכn dεm lεk COVID-19, RSV vayrus |
| Ɔda tin dɛn we kin apin | Ɔstioporosis, maygren, ay kɔlɔstrel, sɔm yay sik dɛn, ɛn fɔ mek dɛn nɔ gri fɔ tek ɔgan transplant |
Aw dɛn kin gi dis tritmɛnt?
כltu, dεn kin gi dεn mכnoklonal antibodi dεm ya as likwid insay wan vein (intravenכs - IV infushכn) . Jɔs lɛk aw yu de gi salin. Dɛn kin du dis na spɛshal yunit (infusion center) na ɔspitul ɔ klinik.
We dɛn gi yu dis tritmɛnt fɔ di fɔs tɛm, di dɔktɔ dɛn go rili tek tɛm wit yu. Bikɔs sɔntɛnde dis mɛrɛsin kin mek yu gɛt siriɔs alɛji, dɛn kin aks yu fɔ mek yu fambul kam wit yu fɔ di fɔs tɛm.
sכm mכnoklכnal antibodi dεm de bak as injεkshכn we de na di bכdi . If na so i bi, nɔs go tren yu aw fɔ gi yusɛf di injɛkshɔn.
Wan pan di big bɛnifit dɛn we dis we fɔ trit gɛt na dat i kin jɔs tɔch di sɛl dɛn we gɛt sik, ɛn dis kin mek di sɛl dɛn we gɛt wɛlbɔdi nɔ pwɛl bɛtɛ. Dis tan lɛk we yu no wan ɛnimi na ples we bɔku pipul dɛn de ɛn kech am ɛn nɔ mek ɛni prɔblɛm to di ɔda wan dɛn.
Wetin na di bɛnifit ɛn prɔblɛm dɛn we kin apin?
Jɔs lɛk ɛni tritmɛnt, sɔm prɔblɛm dɛn de we kin apin. Bɔt nɔ wɔri, yu dɔktɔ go tɛl yu bɔt ɔl dis ɛn tek di tin dɛn we yu nid fɔ tek tɛm wit.
- Infusion Riakshɔn: Dis na di sayd ɛfɛkt we dɛn kin gɛt mɔ. I min se na riakshɔn we kin apin we dɛn gi di mɛrɛsin to di bɔdi ɔ jɔs afta dɛn dɔn gi am. Di sayn dɛm kin bi wae yu gɛt skin rɔsh, fiva, kol, yu nɔr kin ebul fɔ blo, yu kin swet, ɛn yu blɔd prɛshɔn kin chenj. Dɛn kin kɔntrol dɛn tin ya bay we yu slo di rit we di infuzhɔ de insay di tɛm dɛn lɛk dis.
- Siriɔs alɛji: Dɛn tin ya nɔ kin apin so ɔltɛm, bɔt dɛn kin mek pɔsin in layf de pan denja. Fɔ ɛgzampul , anafilaksis na tin we kin apin wantɛm wantɛm ɛn we kin rili bad.
- Saytokin Rilis Sindrom (CRS): dεn kכl am bak ‘saytokin stכm’, dis na we di imyun sistεm de wok pasmak εn bigin fכ pwεl di bכdi in כgan dεm.
- Ɔda prɔblɛm dɛn: Sɔm prɔblɛm dɛn kin dipen pan di sik we dɛn de trit. Fɔ ɛgzampul, di kidni dɛn kin pwɛl bikɔs ɔf di Tumor Lysis Syndrome, we kin apin we dɛn de trit kansa.
Ilɛk wetin apin, di tin we impɔtant pas ɔl fɔ mɛmba na dat, dɛn kin gi dis tritmɛnt ɔnda strikt dɔktɔ in sɔpɔtishɔn. So, if ɛni ɔda tin we nɔ kɔmɔn apin, dɛn fɔ tɛl di wan dɛn we de wok na di dɔktɔ wantɛm wantɛm.
Wetin kin apin afta dɛn dɔn trit am?
Di tɛm we di mɛrɛsin kin tek fɔ go insay yu bɔdi (infusion time) kin difrɛn. I kin tek lɛk wan awa so, dɔn dɛn kin de wach yu fɔ ɔda awa.
Afta tritmɛnt, if yu nɔ taya ɔ yu nɔ fil fayn, yu go ebul fɔ go wok lɛk aw yu kin go wok. Bɔt yu fɔ disayd ɔl dis bay we yu tɔk to yu dɔktɔ, we no yu sik ɛn ɔl yu wɛlbɔdi biznɛs.
If dɛn dɔn gi yu monoklɔnal antibodi tritmɛnt, na yu rayt fɔ aks yu dɔktɔ ɛni kwɛstyɔn, wɔri, ɔ dawt we yu gɛt bɔt am.
Mɛsej we dɛn kin kɛr go na os
- monoklonal antibodi dεm na atifishal antibodi dεm we dεn mek na labכtכri. Dɛn kin ɛp wi yon imyun sistɛm.
- Bikɔs dɛn kin tɔch dɛn tin ya, dɛn kin gɛt smɔl sayd ɛfɛkt pas di tradishɔnal tritmɛnt dɛn.
- Dɛn kin yuz dɛn tin ya fɔ mɛn difrɛn sik dɛn, lɛk kansa, at at, maygren, ɛn COVID-19.
- Bɔku tɛm dɛn kin gi dis mɛrɛsin as infushɔn fɔ salin insay wan vein. Riakshɔn (infusion reactions) kin kɔmɔn insay dis tɛm, bɔt if yu gɛt siriɔs sik, kɔl yu dɔktɔ ɔr di Imejɛnsi Dipatmɛnt (ETU) wantɛm wantɛm.
- Tɔk to yu dɔktɔ ɔltɛm fɔ no if dis tritmɛnt fayn fɔ yu ɛn fɔ no mɔ.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt